Stay up to date with the most recent announcements from the media

Deep Tech

Economic Times

Jun 10, 2025

BluJ Aero’s VTOL Technology

Aerospace startup BluJ Aero’s Co-Founder and Chief Technology Officer Utham Kumar Dharmapuri shares details about the startup’s plans and showcases its first prototype which has been designed for unmanned air cargo logistics.

Lifesciences

BioPharmaAPAC

May 8, 2025

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

Strategic collaboration to co-develop CTX112™ aims to address India’s growing burden of B-cell lymphomas with an off-the-shelf, CRISPR-engineered cell therapy offering scalable production and reduced treatment delays.

Lifesciences

THE KEN

Apr 21, 2025

How a 14-member biotech spent just $10M on a product global pharma wants to lap up

One of the three companies globally to show cell therapy results for dry AMD, an eye disorder affecting nearly 200 million globally, Bengaluru’s Eyestem is also eyeing a disruptive price.

Lifesciences

Ophthamology Times

Apr 14, 2025

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy

Eyecyte-RPE trial involved 9 patients with geographic atrophy, using three ascending dose levels of hiPSC-derived RPE cells. No serious adverse events were reported, and patients showed an average vision improvement of 14.9 letters on ETDRS tests.

No items found.

News

BluJ Aero’s VTOL Technology

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

How a 14-member biotech spent just $10M on a product global pharma wants to lap up

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy